Literature DB >> 21681501

Guillain-barré syndrome following influenza vaccination: causal or coincidental?

James J Sejvar1, Dina Pfeifer, Lawrence B Schonberger.   

Abstract

In 1976, the emergence of a new swine-origin influenza virus prompted concerns about an impending influenza pandemic. Although the outbreak never materialized, the epidemiological link between Guillain-Barre syndrome, a potentially severe peripheral nerve disorder, and the influenza vaccines developed against this virus caught public health officials, clinicians, and the public by surprise. Subsequently, a great deal of scrutiny has been placed on the possible risk of other formulations of influenza vaccine causing this adverse event. Several epidemiologic and biological assessments have been performed in subsequent years to assess this risk, yet considerable uncertainty remains among health care providers about the possible association. The development and rapid implementation of vaccines against the pandemic 2009 A(H1N1) influenza virus once again highlighted this issue. This article reviews the evidence for and against the association of the 1976 influenza vaccines and subsequent seasonal influenza vaccines with the development of Guillain-Barré syndrome.

Entities:  

Year:  2011        PMID: 21681501     DOI: 10.1007/s11908-011-0194-8

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN: 1523-3847            Impact factor:   3.725


  32 in total

1.  Adverse events after Japanese encephalitis vaccination: review of post-marketing surveillance data from Japan and the United States. The VAERS Working Group.

Authors:  H Takahashi; V Pool; T F Tsai; R T Chen
Journal:  Vaccine       Date:  2000-07-01       Impact factor: 3.641

2.  Guillain-Barré syndrome and influenza vaccination in the US Army, 1980-1988.

Authors:  J D Roscelli; J W Bass; L Pang
Journal:  Am J Epidemiol       Date:  1991-05-01       Impact factor: 4.897

3.  Guillain-Barré syndrome: the swine influenza virus vaccine incident in the United States of America, 1976-77: preliminary communication.

Authors:  A D Langmuir
Journal:  J R Soc Med       Date:  1979-09       Impact factor: 5.344

4.  Absence of P2 protein in swine flu vaccines.

Authors:  S W Brostoff; T M White
Journal:  JAMA       Date:  1982 Jan 22-29       Impact factor: 56.272

5.  Guillain-Barré syndrome following influenza vaccination.

Authors:  Penina Haber; Frank DeStefano; Fredrick J Angulo; John Iskander; Sean V Shadomy; Eric Weintraub; Robert T Chen
Journal:  JAMA       Date:  2004-11-24       Impact factor: 56.272

6.  Guillain-Barré syndrome after influenza vaccination in adults: a population-based study.

Authors:  David N Juurlink; Therese A Stukel; Jeffrey Kwong; Alexander Kopp; Allison McGeer; Ross E Upshur; Douglas G Manuel; Rahim Moineddin; Kumanan Wilson
Journal:  Arch Intern Med       Date:  2006-11-13

7.  HLA antigens in Guillain-Barré syndrome.

Authors:  R A Kaslow; J Z Sullivan-Bolyai; B Hafkin; L B Schonberger; L Kraus; M J Moore; E Yunis; R M Williams
Journal:  Neurology       Date:  1984-02       Impact factor: 9.910

8.  Guillain-Barré syndrome in the United States, 1979-1980 and 1980-1981. Lack of an association with influenza vaccination.

Authors:  J E Kaplan; P Katona; E S Hurwitz; L B Schonberger
Journal:  JAMA       Date:  1982-08-13       Impact factor: 56.272

9.  Guillain-Barré syndrome and its relationship to swine influenza vaccination in Michigan, 1976-1977.

Authors:  J G Breman; N S Hayner
Journal:  Am J Epidemiol       Date:  1984-06       Impact factor: 4.897

10.  Immunologic studies of rabies vaccination-induced Guillain-Barré syndrome.

Authors:  T Hemachudha; D E Griffin; W W Chen; R T Johnson
Journal:  Neurology       Date:  1988-03       Impact factor: 9.910

View more
  10 in total

Review 1.  [Guillain-Barré syndrome after exposure to influenza].

Authors:  H-P Hartung; B Keller-Stanislawski; R A Hughes; H C Lehmann
Journal:  Nervenarzt       Date:  2012-06       Impact factor: 1.214

Review 2.  A review of adverse effects of COVID-19 vaccines.

Authors:  Hisham Ahmed Mushtaq; Anwar Khedr; Thoyaja Koritala; Brian N Bartlett; Nitesh K Jain; Syed Anjum Khan
Journal:  Infez Med       Date:  2022-03-01

3.  Ontology-based combinatorial comparative analysis of adverse events associated with killed and live influenza vaccines.

Authors:  Sirarat Sarntivijai; Zuoshuang Xiang; Kerby A Shedden; Howard Markel; Gilbert S Omenn; Brian D Athey; Yongqun He
Journal:  PLoS One       Date:  2012-11-28       Impact factor: 3.240

4.  Risk of Guillain-Barré syndrome after 2010-2011 influenza vaccination.

Authors:  Francesca Galeotti; Marco Massari; Roberto D'Alessandro; Ettore Beghi; Adriano Chiò; Giancarlo Logroscino; Graziella Filippini; Maria Donata Benedetti; Maura Pugliatti; Carmela Santuccio; Roberto Raschetti
Journal:  Eur J Epidemiol       Date:  2013-03-31       Impact factor: 8.082

5.  Guillain-Barré Syndrome (42 Cases) Occurring During a Zika Virus Outbreak in French Polynesia.

Authors:  Louise Watrin; Frédéric Ghawché; Philippe Larre; Jean-Philippe Neau; Stéphane Mathis; Emmanuel Fournier
Journal:  Medicine (Baltimore)       Date:  2016-04       Impact factor: 1.889

6.  Guillain-Barré syndrome after SARS-CoV-2 infection in an international prospective cohort study.

Authors:  Linda W G Luijten; Sonja E Leonhard; Annemiek A van der Eijk; Alex Y Doets; Luise Appeltshauser; Samuel Arends; Shahram Attarian; Luana Benedetti; Chiara Briani; Carlos Casasnovas; Francesca Castellani; Efthimios Dardiotis; Andoni Echaniz-Laguna; Marcel P J Garssen; Thomas Harbo; Ruth Huizinga; Andrea M Humm; Korné Jellema; Anneke J van der Kooi; Krista Kuitwaard; Thierry Kuntzer; Susumu Kusunoki; Agustina M Lascano; Eugenia Martinez-Hernandez; Simon Rinaldi; Johnny P A Samijn; Olivier Scheidegger; Pinelopi Tsouni; Alex Vicino; Leo H Visser; Christa Walgaard; Yuzhong Wang; Paul W Wirtz; Paolo Ripellino; Bart C Jacobs
Journal:  Brain       Date:  2021-12-16       Impact factor: 13.501

7.  Inflammatory demyelinating polyneuropathy after the ChAdOx1 nCoV-19 vaccine may follow a chronic course.

Authors:  Aaron de Souza; Wai M Oo; Pradeep Giri
Journal:  J Neurol Sci       Date:  2022-03-16       Impact factor: 4.553

8.  Guillain-Barré Syndrome, Influenza Vaccination, and Antecedent Respiratory and Gastrointestinal Infections: A Case-Centered Analysis in the Vaccine Safety Datalink, 2009-2011.

Authors:  Sharon K Greene; Melisa D Rett; Claudia Vellozzi; Lingling Li; Martin Kulldorff; S Michael Marcy; Matthew F Daley; Edward A Belongia; Roger Baxter; Bruce H Fireman; Michael L Jackson; Saad B Omer; James D Nordin; Robert Jin; Eric S Weintraub; Vinutha Vijayadeva; Grace M Lee
Journal:  PLoS One       Date:  2013-06-26       Impact factor: 3.240

9.  Guillain-Barré syndrome surveillance during National Influenza Vaccination Campaign, New York, U.S.A., 2009.

Authors:  Gregory P Giambrone; Shelley M Zansky; Millicent Eidson; Pamela G Duncan; Louise-Anne McNutt; Guthrie S Birkhead
Journal:  Emerg Infect Dis       Date:  2013-12       Impact factor: 6.883

10.  A Bayesian Network to Predict the Risk of Post Influenza Vaccination Guillain-Barré Syndrome: Development and Validation Study.

Authors:  Yun Huang; Chongliang Luo; Ying Jiang; Jingcheng Du; Cui Tao; Yong Chen; Yuantao Hao
Journal:  JMIR Public Health Surveill       Date:  2022-03-25
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.